Post by matt on Nov 16, 2019 17:33:51 GMT -5
Thanks, I knew they had that drug pending. Their web site says "The new drug will be marketed through a partnership between Brazilian pharmaceutical industry Biomm, a pioneer in the biotechnology segment for medicines in the country, and South Korean Celltrion Healthcare (CHTC), one of the world's leading biopharmaceuticals." and indeed there is a PF price listed under the Celltrion name but that is for influximab (Remicade) which is a different mAb than trastuzumab. The price is 1873 Reals for 10mg which is much less than the 3289 for the Janssen product (a division of J&J) and the 3289 from Foundation Oswaldo Cruz, a local manufacturer owned by the State of Rio de Janeiro.
I only found two sources for trastuzumab, one for Roche and one for Libbs which is a privately owned Brazilian company.
I only found two sources for trastuzumab, one for Roche and one for Libbs which is a privately owned Brazilian company.